According to FDA-approved prescribing information for Jinteli, if you miss a dose, take it as soon as you remember unless it is almost time for your next dose — do not double doses unless directed by your prescriber to "catch up."
Per FDA-approved prescribing information for Jinteli, Jinteli is a menopausal hormone therapy tablet containing estradiol and norethindrone acetate; missing a single dose may allow return of menopausal symptoms such as hot flashes or sleep disturbances, or may affect hormone levels. Exact steps depend on the form and schedule you use (daily pill, gel, or patch, and whether your regimen is continuous or cyclical). Per FDA-approved prescribing information for Jinteli:
- If you remember the same day: take the dose as soon as you remember and resume your usual schedule.
- If it is near the time of your next dose: skip the missed dose and continue as normal — do not double the next dose unless directed by your prescriber.
- For topical (gel/patch) forms: according to FDA-approved prescribing information for Jinteli, apply the missed dose as soon as you remember if only a short time has passed (generally within 12–24 hours). If longer, resume your normal change day; do not apply extra to make up for the missed application.
- If you have a uterus: according to FDA-approved prescribing information for Jinteli, missing the progestogen (norethindrone acetate) component of combined therapy is the key concern. Missing one dose may allow breakthrough bleeding or may cause temporary symptom return; missing several consecutive progestogen doses may lead to breakthrough bleeding and, if repeated over time, may raise the risk of endometrial problems. Per FDA-approved prescribing information for Jinteli, the FDA labeling for estrogen-containing products includes boxed warnings regarding cardiovascular events, deep vein thrombosis (DVT), pulmonary embolism (PE), endometrial cancer, breast cancer, and probable dementia in women 65 and older; patients who experience any concerning symptoms should contact their prescriber promptly, as whether any individual symptom warrants intervention depends on personal health factors that a clinician must assess, and published guidance from NAMS or ACOG informs how prescribers evaluate them. Contact your prescriber if you miss more than 2–3 days of the progestogen component or if you experience spotting or bleeding.
- If you miss many doses or experience heavy bleeding, severe return of symptoms, or other concerning signs: contact your prescriber for specific guidance — they may advise restarting a steady schedule or an alternative plan.
Contact your prescriber if doses are missed repeatedly or if symptoms change. The labeled guidance for a single missed Jinteli dose is: take it when you remember if it is close in time, skip it if the next dose is due, never double up unless directed by your prescriber, and contact your clinician if multiple doses are missed or if you experience new or heavy bleeding.